CEO
inGENEious RX Incorporated
For over a decade, Dr. Winslow has provided pharmacogenomics stakeholders with solutions to optimize clinical pharmacogenomics testing. Her work includes training Doctors of Clinical Pharmacy to work for stakeholders as clinical pharmacogenomics specialists. Before founding inGENEious RX Inc., a boutique PGx consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services.
Dr. Winslow is an advanced pharmacy practice experience preceptor for the Manchester University School of Pharmacy Master of Science in Pharmacogenomics Program and a registered trainer for the University of Pittsburgh’s Test2Learn™ Community Pharmacogenetics Certificate Program. She is a member of the Clinical Pharmacogenetics Implementation Consortium, the National Council for Prescription Drug Programs (NCPDP) PGx Task Force, and the Get the Medications Right Institute. Dr. Winslow earned her bachelor of science in biology and doctor of clinical pharmacy degrees from Campbell University.
Wednesday, November 20, 2024
10:00 AM – 10:50 AM PST